Skip to main content

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

RES-Q PLUS: Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality

IP: Carlos Molina Cateriano
Collaborators: Noelia Rodríguez Villatoro, Federica Rizzo, David Rodriguez Luna, Carole Conforti
Funding agency: EUROPEAN COMMISSION
Funding: 396730
Reference: RES-Q PLUS_HE-HLTH-TOOL21
Duration: 01/11/2022 - 31/10/2026

VALIDATE: Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Maria Victoria Sala Sanz de Madrid, Cristina Guirao Martinez, Claudia Meza Burgos, Federica Rizzo, Ester Sanchez Gavilan, David Rodriguez Luna
Funding agency: EUROPEAN COMMISSION
Funding: 567950
Reference: VALIDATE_HE-HLTH-DISEASE21
Duration: 01/05/2022 - 30/04/2026

Empower-ICH: eficacia de la implementación de un sistema de telemonitorización de la presión arterial ambulatoria en pacientes con hemorragia intracerebral

IP: David Rodriguez Luna
Collaborators: Noelia Rodríguez Villatoro, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 38720
Reference: PI20/00834
Duration: 01/01/2021 - 30/06/2025

Estudio de la implicación de la distribución de la apolipoproteína J (ApoJ/Clusterin) en lipoproteínas circulantes en la Angiopatía Amiloide Cerebral

IP: Maria Mar Hernandez Guillamon
Collaborators: Guillem Colell Dinares, David Rodriguez Luna
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI17/00275
Duration: 01/01/2018 - 31/12/2020

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Roser Navarro García

Roser Navarro García

Infectious Diseases
Read more
Mª Carmen López  Arribas

Mª Carmen López Arribas

Research technician
Molecular Medical Imaging
Read more
Jesús Francisco Lopez Lozano

Jesús Francisco Lopez Lozano

Read more
Jorge Serra Pueyo

Jorge Serra Pueyo

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.